We know how to fight for our client’s right to compensation in Zantac/Ranitidine-related injury cases.
Compensation for Zantac®/Ranitidine Cancer Patients Nationwide
Morrow & Sheppard LLP handle cases involving serious bodily injury and death caused by contaminated Zantac®/Ranitidine and their generic counterparts’ products. If you or a loved one has developed cancer as a result of their use of Zantac®, you or a loved one may be entitled to compensation. Act now to protect your legal rights, contact us for a FREE, confidential consultation today!
Handling Zantac® Lawsuit Claims Throughout the United States
CONTACT US FOR A FREE, CONFIDENTIAL CASE REVIEW WITH OUR EXPERIENCED ZANTAC/RANITIDINE LAWSUIT LAWYERS: 866-385-8377
Cancer Types Linked to Zantac®/Ranitidine Use
The types of cancer thus far associated with Zantac® and generic forms of Ranitidine may include:
No Fee Unless We Win
At Morrow & Sheppard LLP, we understand the hardships injured victims and their loved ones face as they try to heal and make sense of their Zantac/Ranitidine-related injuries. That’s why we work on a contingency-fee basis, which means no fee unless we win your case. Our fee is a percentage of the verdict or settlement we obtain for you.
NDMA in Zantac (Ranitidine)
N-Nitrosodimethylamine (NDMA) has recently entered the FDA spotlight for its presence in Ranitidine Hydrochloride (“Ranitidine”), originally sold under the trade name Zantac®. Ranitidine is an H2 (histamine-2) blocker developed to decrease stomach acid production, and is used to treat peptic ulcer disease, gastroesophageal reflux disease, and Zollinger-Ellison Syndrome. It is more commonly used over-the-counter and by prescription to prevent and relieve heartburn.
The recent recalls and FDA-withdrawals of Ranitidine products and Zantac® from the U.S. market are directly related to the discovery of dangerous levels of NDMA within these medications. The common Zantac® and Ranitidine products at issue include:
- Zantac® 150 Tablets
- Zantac® 150 Maximum Strength
- Zantac® 150 Maximum Strength Cool Mint
- Zantac® 75 Tablets
- Wal-Zan® 150
- Wal-Zan® 75
- Heartburn Relief (ranitidine)
- Acid Reducer (ranitidine)
- Acid Control (ranitidine)
Contact a Nationwide Zantac Lawsuit Lawyer for a Free, Confidential Consultation Today!
Timeline of Zantac (Ranitidine)
Important events in the history of Zantac/ranitidine include:
- 1978: GSK scientist John Bradshaw develops Zantac
- 1981: Ranitidine first introduced
- 1982: National Cancer Institute rat study shows “significant DNA fragmentation” from ranitidine
- 1986: Zantac tops $1 billion in annual sales
- 1997: Zantac sold in generic form
- 2004: Zantac first sold over the counter
- 2018: Blood pressure drugs containing ranitidine recalled due to NDMA
- September 2019: CVS, Wal-Mart, Rite Aid, Walgreen’s, and others start removing Zantac from shelves
- October 2019: FDA declares there are “unacceptable levels” of NDMA in Zantac and ranitidine. Sanofi and Teva begin recalls.
- April 2020: FDA orders all ranitidine removed from shelves
Our Personal Injury Lawyers Assist Zantac® Victims Nationwide
If you or a loved one has been seriously injured or developed cancer as a result of their use of Zantac®, you or a loved one must work with an experienced Zantac lawsuit lawyer to discuss your legal options. At Morrow & Sheppard LLP, we have handled more than a billion dollars on behalf of our clients throughout the United States. We offer a free, no-obligation consultation, contact us today! You don’t pay us unless we win your case.
We can be reached nationwide at 800-489-2216.
You can also reach us by entering your information into the contact form here.